Stay updated on ELiSA Study: Lixivaptan in ADPKD Clinical Trial
Sign up to get notified when there's something new on the ELiSA Study: Lixivaptan in ADPKD Clinical Trial page.

Latest updates to the ELiSA Study: Lixivaptan in ADPKD Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new system revision entry (Revision: v3.4.2) has been added. The older funding-notice banner and Revision: v3.4.1 have been removed.SummaryDifference0.6%

- Check21 days agoChange DetectedAdded a site-wide notice about government funding and the NIH Clinical Center status, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check28 days agoChange DetectedThe changes are cosmetic updates to the history display, including a glossary, color-coded highlights, and revision banners, with capitalization adjusted in 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check42 days agoChange DetectedThe record history shows Revision: v3.3.4 replacing Revision: v3.3.3, indicating a small update to the page metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedNew Revision: v3.3.3 appears in the record history. The footer/history no longer shows 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.SummaryDifference0.2%

- Check85 days agoChange DetectedThe revision label changed from v3.3.1 to v3.3.2, and no study data, statuses, or contact information appears altered; to avoid alerts from small changes, set an alert condition.SummaryDifference0.1%

Stay in the know with updates to ELiSA Study: Lixivaptan in ADPKD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ELiSA Study: Lixivaptan in ADPKD Clinical Trial page.